Browse by category

Metabolic and bariatric surgery offers significantly greater long-term protection against major adverse cardiovascular events (MACE, eg heart attack, stroke) and death than GLP-1 drugs in older adults with obesity and diabetes, according to real-world analysis study, ‘Cardiometabolic outcomes of metabolic surgery versus GLP-1 receptor agonists in older adults with diabetes and obesity (Abstract ID: 4719)’, presented at the annual meeting of the American Society for Metabolic

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...